Psychiatric Emergencies And Safety - USMLE Step 2

SECTION 1

Historical Context & Motivation

The recognition that psychiatric emergencies require specialized clinical protocols has evolved considerably over the past two centuries. In earlier eras, individuals experiencing acute psychosis, suicidal ideation, or violent decompensation were often managed through restraint or institutionalization with little regard for the underlying pathophysiology or patient dignity. The gradual shift toward evidence-based crisis intervention reflects broader changes in psychiatry — from custodial care to a model rooted in neurobiological understanding, pharmacotherapy, and therapeutic de-escalation. For clinicians preparing for the USMLE Step 2 CK, mastery of psychiatric emergencies is essential, as these scenarios test the integration of diagnostic acumen, pharmacological knowledge, medicolegal awareness, and interpersonal communication under time pressure.

1793 • Philippe Pinel and Moral Treatment

Pinel famously unchained patients at the Bicêtre Hospital in Paris, inaugurating the moral treatment movement that prioritized humane management over punitive restraint during behavioral crises.

1952 • Chlorpromazine Introduced

The introduction of chlorpromazine provided the first effective pharmacological tool for rapid tranquilization of acutely psychotic or agitated patients, transforming emergency psychiatric care.

1963 • Community Mental Health Act

President Kennedy's legislation promoted deinstitutionalization and the development of community-based crisis intervention centers, shifting psychiatric emergency management from asylums to emergency departments and outpatient settings.

1988 • EMTALA and Psychiatric Emergencies

The Emergency Medical Treatment and Labor Act (EMTALA) mandated that all patients presenting to the emergency department — including those with psychiatric complaints — receive a medical screening examination and stabilization regardless of ability to pay.

2010s • Modern De-escalation and Safety Frameworks

The adoption of standardized verbal de-escalation protocols and trauma-informed care models became widespread, reducing reliance on physical restraint and improving outcomes in psychiatric emergency settings.

Despite these advances, psychiatric emergencies remain among the most challenging clinical encounters. The central question that modern emergency psychiatry addresses is: How does a clinician rapidly identify, triage, and manage life-threatening psychiatric conditions while simultaneously ensuring the safety of the patient, staff, and other individuals in the treatment environment? This lesson provides the systematic framework needed to answer that question on examination day and in clinical practice.

SECTION 2

Core Principles & Definitions

A psychiatric emergency is defined as any disturbance in thought, feeling, or behavior that requires immediate intervention to prevent harm to the patient or to others. Unlike scheduled psychiatric evaluations, emergencies demand rapid risk stratification, an abbreviated but targeted differential diagnosis, and the initiation of acute treatment — often before a complete history is available. The foundational principles that guide safe and effective management can be organized into four domains: safety, medical stabilization, psychiatric assessment, and disposition.

Safety First (ABCs of Psychiatry)

Before any psychiatric assessment, ensure the physical safety of the patient, clinician, and bystanders. Remove potential weapons, maintain a clear exit path, and have security available. In parallel, rule out medical etiologies (hypoglycemia, intoxication, delirium) that may mimic psychiatric illness.

Medical Rule-Out

Every psychiatric emergency begins with a medical screening examination. Altered mental status, new-onset psychosis after age 40, abnormal vital signs, or focal neurological findings should raise suspicion for an organic cause and warrant urgent laboratory and imaging evaluation.

Risk Stratification

Assess for imminent danger using structured tools. Evaluate suicidal ideation (plan, intent, means, access), homicidal ideation, and the capacity for self-care. Risk factors and protective factors must be weighed together.

Least Restrictive Intervention

Management should always proceed from least to most restrictive: verbal de-escalation → oral pharmacotherapy → intramuscular medication → physical or mechanical restraint. This principle is both an ethical imperative and a medicolegal standard.

Disposition and Follow-Up

After stabilization, determine the appropriate level of care: discharge with outpatient follow-up, voluntary psychiatric admission, or involuntary commitment when criteria for danger to self or others are met and the patient refuses treatment.

✦

KEY TAKEAWAY

Think of psychiatric emergency management like the approach a pilot uses during an in-flight crisis: first, stabilize the aircraft (safety), then identify the malfunction (medical and psychiatric differential), then choose the most appropriate landing site (disposition). Just as a pilot always follows the checklist — aviate, navigate, communicate — the emergency psychiatrist follows a systematic protocol even under extreme time pressure. Skipping the medical rule-out in a psychiatric emergency is analogous to ignoring a warning light in the cockpit: the underlying cause may be something entirely different from what it appears.

SECTION 3

Visual Explanation — Psychiatric Emergency Triage Algorithm

The triage algorithm proceeds from top to bottom: safety first (cyan), then medical screening (violet), followed by the critical branch point of organic versus primary psychiatric etiology (amber). If psychiatric, the clinician assesses for imminent danger and determines involuntary hold versus voluntary treatment/discharge.

The algorithm above illustrates the systematic approach every clinician should employ. Note that the first branch point — organic versus primary psychiatric cause — is arguably the single most important decision in emergency psychiatry. A patient presenting with acute agitation and visual hallucinations may appear psychotic, but the underlying cause could be anticholinergic toxicity, hepatic encephalopathy, or a postictal state. Failing to screen for medical etiologies is one of the most commonly tested pitfalls on the USMLE Step 2 CK. The second critical branch — imminent danger assessment — determines whether an involuntary hold is legally and clinically justified.

SECTION 4

Mechanism — Acute Agitation and Pharmacological Management

While psychiatric emergencies do not lend themselves to mathematical equations in the traditional sense, a rigorous understanding of the pharmacological mechanisms underlying rapid tranquilization is essential. Acute agitation is mediated by excessive catecholaminergic and glutamatergic activity in limbic and prefrontal circuits, and pharmacological intervention targets these pathways through three principal drug classes.

Antipsychotics (First-Generation and Second-Generation)

First-generation antipsychotics such as haloperidol (typically 5 mg IM) act primarily via D₂ receptor antagonism in the mesolimbic pathway, reducing psychotic symptoms and agitation. Second-generation agents like olanzapine (10 mg IM) and ziprasidone (20 mg IM) also antagonize 5-HT₂A receptors, contributing additional sedation and a potentially lower risk of acute extrapyramidal symptoms. A critical safety point: olanzapine IM and benzodiazepines IM must not be given together due to the risk of cardiorespiratory depression — this is a high-yield test point.

Benzodiazepines

Lorazepam (2 mg IM or IV) is the benzodiazepine of choice in psychiatric emergencies because it has reliable intramuscular absorption (unlike diazepam and chlordiazepoxide), no active metabolites, and an intermediate half-life. Benzodiazepines enhance GABA-A receptor–mediated chloride influx, producing anxiolysis, sedation, and anticonvulsant effects. They are the first-line treatment for agitation due to alcohol or sedative-hypnotic withdrawal, catatonic excitement, and stimulant intoxication — settings where antipsychotics may be harmful.

The 'B-52' Combination and Variants

The colloquially named B-52 — Benadryl (diphenhydramine 50 mg) + Haldol (haloperidol 5 mg) + Ativan (lorazepam 2 mg) IM — represents a classic combination for severe undifferentiated agitation. The diphenhydramine provides additional sedation and prophylaxis against extrapyramidal symptoms. This combination can be administered in a single injection site. Newer protocols substitute second-generation antipsychotics, but the B-52 remains widely used and commonly tested.

⚠

HIGH-YIELD WARNING

Always obtain an ECG before or soon after administering antipsychotics, especially in patients receiving multiple QTc-prolonging agents. QTc > 500 ms is a threshold that significantly increases the risk of torsades de pointes. Haloperidol and ziprasidone are among the antipsychotics with the greatest QTc-prolonging potential.

SECTION 5

Classification of Major Psychiatric Emergencies

Psychiatric emergencies can be classified into several major categories, each with distinct etiologies, presentations, and management strategies. The following diagram and table provide a comprehensive classification framework organized by the primary presenting concern.

This classification diagram divides psychiatric emergencies into four major categories — suicidality (red), acute agitation (amber), psychosis (cyan), and drug-related emergencies (green) — each with specific subtypes. Cross-cutting medicolegal and cultural considerations apply to all categories.

Emergency Category	Key Assessment Focus	First-Line Intervention	Critical Pitfall
Suicidal Patient	Plan, intent, means, access, prior attempts, protective factors (Columbia Suicide Severity Rating Scale)	1:1 observation, remove lethal means, safety planning; admit if high risk	Discharging without means restriction or follow-up plan
Acute Agitation	Etiology (psychotic vs. substance vs. medical), vital signs, prior medication response	Verbal de-escalation → PO lorazepam or olanzapine → IM if refused	Using antipsychotics for stimulant intoxication or alcohol withdrawal
Acute Psychosis	First episode vs. relapse, substance use screen, medical causes (especially in patients > 40)	Antipsychotic (haloperidol or SGA) ± benzodiazepine for comorbid anxiety/agitation	Missing anti-NMDA receptor encephalitis, thyroid storm, or CNS infection
NMS	Hyperthermia, rigidity, autonomic instability, elevated CK, mental status changes	Discontinue all antipsychotics, IV fluids, cooling, dantrolene ± bromocriptine	Confusing NMS with serotonin syndrome or malignant hyperthermia
Serotonin Syndrome	Clonus (especially lower extremity), hyperreflexia, hyperthermia, agitation, diarrhea; recent serotonergic drug addition	Discontinue serotonergic agents, cyproheptadine (5-HT₂A antagonist), supportive care	Failing to recognize mild forms; not asking about all serotonergic medications (including tramadol, linezolid)

Summary of major psychiatric emergencies with assessment focus, first-line interventions, and commonly tested pitfalls.

SECTION 6

Worked Example — Acute Agitation in the Emergency Department

The following clinical vignette demonstrates the systematic application of psychiatric emergency principles to a commonly tested USMLE Step 2 CK scenario.

Clinical Vignette: 28-Year-Old Male with Acute Agitation

1
Step 1 — Presentation and Initial Safety

A 28-year-old man with a known history of schizophrenia is brought to the ED by police after threatening neighbors with a baseball bat. He is pacing, shouting, and appears to be responding to internal stimuli. Vital signs: BP 148/92, HR 112, T 37.2°C, RR 20, SpO₂ 98%. Safety actions: Security is present, the patient is moved to a safe room with exits for staff, sharp objects are removed, and the clinician maintains a non-threatening posture with adequate interpersonal distance.

Environment is secured; staff can proceed with assessment.
2
Step 2 — Verbal De-escalation Attempt

The clinician introduces themselves calmly, acknowledges the patient's distress ('I can see you're upset — I want to help'), and offers choices: 'Would you like some water? Would you prefer to sit or stand?' The patient continues pacing but engages briefly. De-escalation is partially successful but the patient refuses oral medications and escalates his agitation, punching a wall.

Verbal de-escalation insufficient; pharmacological intervention indicated.
3
Step 3 — Medical Rule-Out

A focused medical assessment is conducted. Vital signs are abnormal (tachycardia, hypertension) but not suggestive of an acute medical emergency. Pupils are mid-size and reactive. No diaphoresis or rigidity. There is no evidence of head trauma. A point-of-care glucose is 102 mg/dL. His medication list confirms he has been on risperidone 4 mg daily but reportedly stopped it 2 weeks ago. A urine drug screen is ordered.

No immediate medical cause identified; presentation consistent with psychotic relapse due to medication non-adherence.
4
Step 4 — Pharmacological Management

Given the known history of schizophrenia and likely relapse, an IM antipsychotic is appropriate. The clinician orders haloperidol 5 mg IM + lorazepam 2 mg IM + diphenhydramine 50 mg IM (the B-52 protocol). Within 25 minutes, the patient's agitation decreases significantly. He sits down and is able to answer basic questions. An ECG obtained post-medication shows a QTc of 445 ms.

Agitation managed successfully; QTc within acceptable range (< 500 ms).
5
Step 5 — Risk Assessment and Disposition

After sedation, the patient reports auditory hallucinations commanding him to 'protect himself.' He denies suicidal ideation but endorses that he 'has to fight' his neighbors because 'they are trying to poison' him. He does not believe he is ill and refuses voluntary admission. Given active psychosis with paranoid delusions, command auditory hallucinations, violent behavior, and medication non-adherence, the clinician determines he meets criteria for involuntary psychiatric hold (danger to others) and initiates the commitment process per state law.

Disposition: Involuntary psychiatric admission for stabilization and medication re-initiation.

SECTION 7

High-Yield Comparisons — NMS vs. Serotonin Syndrome vs. Malignant Hyperthermia

One of the most commonly tested areas in psychiatry on the USMLE Step 2 CK is the differentiation of drug-induced hyperthermic syndromes. These three conditions share overlapping features — hyperthermia, altered mental status, and autonomic instability — but differ critically in their precipitants, examination findings, and treatments. Confusing them can lead to life-threatening mismanagement.

Feature	NMS	Serotonin Syndrome	Malignant Hyperthermia
Precipitant	Dopamine antagonists (antipsychotics, metoclopramide) or dopamine agonist withdrawal	Serotonergic agents (SSRIs, SNRIs, MAOIs, tramadol, linezolid, triptans)	Volatile anesthetics, succinylcholine
Onset	Days to weeks after starting/increasing dose	Hours (typically within 24h of drug change)	Minutes to hours during anesthesia
Muscle Tone	"Lead-pipe" rigidity	Clonus, hyperreflexia	Generalized rigidity
Reflexes	Decreased (due to rigidity)	Increased (hyperreflexia is hallmark)	Decreased
Pupils	Normal	Dilated (mydriasis)	Normal
Lab Findings	Elevated CK (often markedly), leukocytosis, metabolic acidosis	CK may be mildly elevated; primarily a clinical diagnosis	Markedly elevated CK, hyperkalemia, elevated CO₂
Treatment	Stop antipsychotic, dantrolene ± bromocriptine, cooling, IV fluids	Stop serotonergic agents, cyproheptadine, benzodiazepines, cooling	Stop triggering agent, dantrolene, cooling, hyperkalemia management

Comparison of three drug-induced hyperthermic emergencies commonly tested on USMLE Step 2 CK.

✦

KEY TAKEAWAY

The simplest mnemonic to differentiate these three conditions at the bedside: NMS is slow and stiff (develops over days, lead-pipe rigidity, decreased reflexes), while serotonin syndrome is fast and twitchy (develops within hours, clonus, hyperreflexia, mydriasis). Think of NMS like a rusty machine that grinds to a halt over time, and serotonin syndrome like an electrical system that rapidly overloads with excess excitatory current. Malignant hyperthermia occurs exclusively in the operative setting — if the patient is not under anesthesia, it is not malignant hyperthermia.

SECTION 8

Advanced Considerations — Capacity, Involuntary Commitment, and Special Populations

Beyond the acute clinical management of psychiatric emergencies, clinicians must navigate complex medicolegal frameworks. Two concepts tested heavily on the USMLE Step 2 CK are decisional capacity and involuntary commitment. Capacity is a clinical determination made by the treating physician (not a legal determination of competency, which requires a court). A patient must demonstrate four abilities to have capacity: the ability to communicate a choice, understand relevant information, appreciate the situation and its consequences, and reason about treatment options. A psychiatric diagnosis alone does not negate capacity — a patient with schizophrenia may have full capacity to refuse a particular treatment.

Concept	Capacity (Clinical)	Competency (Legal)
Determined by	Any treating physician	A judge (court proceeding)
Scope	Task-specific (e.g., capacity to refuse intubation)	Global or domain-specific (e.g., financial competency)
Fluctuation	May fluctuate (e.g., delirium); reassess as needed	Generally a more stable determination
If absent	Surrogate decision-maker activated; emergency treatment may proceed	Guardian appointed by court

Capacity versus competency — a distinction frequently tested on the USMLE.

Involuntary commitment criteria vary by state but generally require that the patient has a mental illness and poses an imminent danger to self or others, or is gravely disabled (unable to provide for basic needs such as food, clothing, and shelter). The Tarasoff duty requires clinicians in many jurisdictions to take steps to protect identifiable third parties when a patient makes a credible threat of violence against them. This may include warning the intended victim, notifying law enforcement, or hospitalizing the patient. Understanding the interplay between patient autonomy, public safety, and the clinician's legal obligations is a critical component of managing psychiatric emergencies at the advanced level.

ℹ

SPECIAL POPULATIONS

Pediatric patients, geriatric patients, pregnant women, and patients with intellectual disability or autism spectrum disorder require modified approaches. In children and adolescents, always screen for abuse. In elderly patients, delirium is far more common than primary psychiatric illness and must be excluded. In pregnant patients, medication safety profiles change significantly — lorazepam is generally preferred over antipsychotics when possible, and lithium is contraindicated in the first trimester (Ebstein anomaly). Always tailor the intervention to the specific vulnerabilities of the population.

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

A 32-year-old man is brought to the emergency department by police after threatening to jump off a bridge. He states he has been feeling hopeless since losing his job 2 weeks ago. He reports drinking a fifth of whiskey daily for the past month. He has no prior psychiatric history. Which of the following is the most important initial step in the management of this patient?

A. Administer lorazepam for alcohol withdrawal prophylaxis
B. Perform a comprehensive suicide risk assessment
C. Obtain a psychiatric consultation for involuntary commitment
D. Start the patient on an SSRI for major depressive disorder
E. Obtain a blood alcohol level and urine drug screen

Show answer

The correct answer is B. In any patient presenting with suicidal ideation or behavior, the most critical initial step is performing a comprehensive suicide risk assessment, which includes evaluating the presence of a plan, intent, access to means, and risk and protective factors. This assessment guides all subsequent management decisions. Choice A is incorrect because while alcohol withdrawal is an important consideration, addressing the immediate safety concern of suicidality takes priority; benzodiazepines would be administered based on withdrawal symptoms using a validated scale such as CIWA. Choice C is premature because involuntary commitment may be considered after the risk assessment is completed and the patient's willingness to engage in voluntary treatment is explored. Choice D is incorrect because starting an SSRI is not an emergency intervention and would not be initiated before a thorough assessment; moreover, depression secondary to substance use and acute stressors requires further evaluation. Choice E is relevant to the workup but does not take precedence over assessing the patient's acute safety and suicide risk.

Question 2: BASIC CALCULATION

A 45-year-old woman with a history of bipolar I disorder is brought to the emergency department by her husband. She has not slept in 4 days, is speaking rapidly, and believes she has special powers. She is pacing the room, yelling at staff, and has attempted to strike a nurse. Her temperature is 37.2°C (99°F), heart rate is 112/min, blood pressure is 148/92 mmHg, and respiratory rate is 20/min. Which of the following is the most appropriate pharmacologic intervention for acute agitation in this patient?

A. Haloperidol 5 mg IM, lorazepam 2 mg IM, and diphenhydramine 50 mg IM
B. Lithium carbonate 600 mg orally
C. Chlorpromazine 100 mg IM
D. Fluoxetine 20 mg orally
E. Valproic acid 500 mg orally

Show answer

The correct answer is A. The combination of haloperidol, lorazepam, and diphenhydramine (commonly referred to as a 'B52' or similar IM cocktail) is a standard emergency treatment for acute severe agitation, particularly when the patient is physically aggressive and oral medications are not feasible. Haloperidol provides rapid antipsychotic effect, lorazepam addresses agitation and lowers the seizure threshold concern, and diphenhydramine reduces the risk of extrapyramidal side effects from haloperidol. Choice B is incorrect because lithium has a slow onset of action and requires monitoring of serum levels; it is not used for acute agitation management. Choice C is incorrect because chlorpromazine, while an antipsychotic, causes significant hypotension (especially IM administration) and is generally avoided in the acute agitation setting when safer alternatives exist. Choice D is incorrect because fluoxetine is an SSRI with no role in acute agitation and could potentially worsen mania in a bipolar patient. Choice E is incorrect because oral valproic acid has a delayed onset and is used as a mood stabilizer for maintenance or acute mania treatment but is not appropriate for managing immediate dangerous agitation.

Question 3: INTERMEDIATE

A 28-year-old woman is brought to the emergency department after being found unresponsive by her roommate. Empty bottles of acetaminophen and sertraline are found at the scene. Her roommate states the patient recently broke up with her boyfriend and had been talking about 'ending it all.' In the emergency department, the patient is drowsy but arousable. Her temperature is 37.8°C (100°F), heart rate is 105/min, blood pressure is 110/70 mmHg, and respiratory rate is 18/min. Initial labs show AST 85 U/L, ALT 78 U/L, INR 1.1, and an acetaminophen level of 180 mcg/mL drawn 4 hours post-ingestion. Which of the following is the most appropriate next step in management?

A. Administer activated charcoal
B. Begin intravenous N-acetylcysteine (NAC)
C. Obtain a psychiatry consultation before initiating medical treatment
D. Administer cyproheptadine for serotonin syndrome
E. Monitor liver function tests and repeat acetaminophen level in 4 hours

Show answer

The correct answer is B. An acetaminophen level of 180 mcg/mL at 4 hours post-ingestion falls above the treatment line on the Rumack-Matthew nomogram (which begins at 150 mcg/mL at 4 hours), indicating a high risk of hepatotoxicity and necessitating immediate N-acetylcysteine administration. NAC is most effective when given within 8 hours of ingestion but provides benefit even when administered later. Choice A is incorrect because activated charcoal is most effective within 1-2 hours of ingestion; at 4 hours post-ingestion, its benefit is minimal and it does not replace the need for NAC. Choice C is incorrect because medical stabilization always takes priority over psychiatric evaluation in an overdose; the patient's life-threatening medical condition must be addressed first. Choice D is incorrect because while sertraline overdose can cause serotonin syndrome, the patient's presentation (drowsiness, mild tachycardia without clonus, rigidity, or hyperthermia) does not meet criteria for serotonin syndrome, and the acetaminophen toxicity is the more immediate concern. Choice E is incorrect because watchful waiting is inappropriate when the acetaminophen level is above the treatment threshold; delaying NAC administration increases the risk of irreversible hepatic damage.

Question 4: APPLIED

A 19-year-old college student is brought to the emergency department by campus police after his roommate called 911. The patient locked himself in his dorm room, sent a text message to his ex-girlfriend saying 'you won't have to worry about me anymore,' and was found holding a knife to his wrist. He has superficial lacerations on his left forearm. He has a history of borderline personality disorder with two prior psychiatric hospitalizations for suicidal gestures. In the emergency department, he is calm, cooperative, and states he 'wasn't really going to do it' and wants to go home. He denies current suicidal ideation. Which of the following is the most appropriate next step?

A. Discharge with outpatient psychiatry follow-up within 1 week
B. Discharge with a safety plan and crisis hotline numbers
C. Obtain a formal psychiatric evaluation prior to disposition
D. Initiate involuntary psychiatric hold immediately
E. Treat the lacerations and discharge after the patient signs a no-suicide contract

Show answer

The correct answer is C. Despite the patient's current calm demeanor and denial of suicidal ideation, the clinical scenario (farewell text message, holding a knife to his wrist, superficial lacerations, history of prior suicidal gestures and borderline personality disorder) represents significant risk factors that require a formal psychiatric evaluation before any disposition decision can be made. A psychiatrist or qualified mental health professional should assess the patient's current risk, determine the function of the behavior, and evaluate for comorbid conditions before safely discharging or admitting the patient. Choice A is incorrect because discharging the patient without a formal psychiatric evaluation would be premature and potentially dangerous given the high-risk presentation, regardless of his current denial of suicidal ideation. Choice B is incorrect for the same reason; while a safety plan is an important component of discharge planning, it should only follow a comprehensive psychiatric assessment and determination that outpatient management is safe. Choice D is incorrect because involuntary commitment requires a determination that the patient poses an imminent danger to themselves or others; a formal assessment is needed before making this determination, and the patient is currently cooperative. Choice E is incorrect because no-suicide contracts have no evidence of effectiveness in preventing suicide and should never be used as a substitute for a thorough risk assessment; they provide false reassurance and do not constitute adequate clinical care.

Question 5: CRITICAL THINKING

A 55-year-old man with a history of schizophrenia, type 2 diabetes mellitus, and hypertension is brought to the emergency department by emergency medical services after being found wandering in traffic, talking to himself, and appearing confused. He was recently discharged from a psychiatric facility 3 days ago. His medications include clozapine, metformin, and lisinopril. On examination, his temperature is 39.4°C (103°F), heart rate is 130/min, blood pressure is 90/60 mmHg, and respiratory rate is 22/min. He is diaphoretic, confused, and has diffuse muscle rigidity. Laboratory studies show WBC 1,200/μL, creatine kinase 8,500 U/L, and creatinine 2.1 mg/dL. Which of the following is the most likely diagnosis?

A. Serotonin syndrome
B. Neuroleptic malignant syndrome
C. Malignant hyperthermia
D. Sepsis secondary to clozapine-induced agranulocytosis
E. Diabetic ketoacidosis

Show answer

The correct answer is B. This patient presents with the classic tetrad of neuroleptic malignant syndrome (NMS): hyperthermia, muscle rigidity, altered mental status, and autonomic instability (tachycardia, hypotension, diaphoresis). The elevated creatine kinase (8,500 U/L) reflects rhabdomyolysis from severe muscle rigidity, and the elevated creatinine suggests acute kidney injury, likely from myoglobin deposition. Clozapine, an atypical antipsychotic, is a known cause of NMS, and the recent psychiatric discharge suggests possible medication changes or reinitiation that may have precipitated this syndrome. Choice A is incorrect because serotonin syndrome, while also presenting with hyperthermia and altered mental status, is characterized by neuromuscular hyperactivity (clonus, hyperreflexia, myoclonus) rather than the diffuse 'lead-pipe' rigidity seen in NMS; additionally, the patient is not on serotonergic medications. Choice C is incorrect because malignant hyperthermia occurs in the setting of volatile anesthetic agents or succinylcholine exposure during surgery, not in an outpatient setting. Choice D is a strong distractor because clozapine is well known to cause agranulocytosis, and the WBC of 1,200/μL is indeed consistent with this; however, sepsis alone does not explain the severe muscle rigidity and markedly elevated CK, making NMS the unifying diagnosis (notably, leukopenia can also occur in NMS, though leukocytosis is more common). Choice E is incorrect because diabetic ketoacidosis, while a possible complication of clozapine and diabetes, would present with Kussmaul respirations, fruity breath, and metabolic acidosis rather than diffuse muscle rigidity and extremely elevated CK levels.

SUMMARY

Summary — Psychiatric Emergencies and Safety

Summary

Psychiatric emergencies require a systematic approach that prioritizes environmental safety before any clinical assessment. The clinician must first rule out medical etiologies — including hypoglycemia, intoxication, delirium, and encephalitis — before attributing symptoms to a primary psychiatric disorder. Risk stratification for suicidality and violence guides disposition, with assessment tools such as the Columbia Suicide Severity Rating Scale providing structured frameworks. Management proceeds along a least-restrictive intervention hierarchy: verbal de-escalation → oral medications → intramuscular pharmacotherapy → physical restraint. Key pharmacological agents include haloperidol, lorazepam, olanzapine, and the B-52 combination, with agent selection dictated by the etiology of agitation.

Three drug-induced hyperthermic syndromes — NMS (slow onset, rigidity, decreased reflexes), serotonin syndrome (rapid onset, clonus, hyperreflexia), and malignant hyperthermia (operative setting only) — must be distinguished by their onset, physical examination findings, and precipitants. Medicolegal concepts including decisional capacity (communicate, understand, appreciate, reason), involuntary commitment criteria (danger to self, danger to others, grave disability), and the Tarasoff duty to protect are frequently tested. Finally, always consider anti-NMDA receptor encephalitis in any young patient with first-episode psychosis and atypical features — this treatable condition masquerades as a psychiatric emergency but requires immunological, not psychiatric, management.